Point72 Asia (Singapore)’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$19.2K	Buy	+1,369	New	+$19.2K	﹤0.01%	735
2024 Q4	–	Sell	-3,764	Closed	-$110K	–	949
2024 Q3	$110K	Sell	3,764 -4,571	-55%	-$133K	0.02%	522
2024 Q2	$194K	Buy	+8,335	New	+$194K	0.04%	302